SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 7 )*
ALLIED HEALTHCARE PRODUCTS, INC.
--------------------------------------------------------------------------------
(Name of Issuer)
COMMON STOCK
--------------------------------------------------------------------------------
(Title of Class of Securities)
019222 10 8
--------------------------------------------------------------------------------
(CUSIP Number)
JOHN D. WEIL
200 N. BROADWAY, SUITE 825, ST. LOUIS, MISSOURI 63102 (314) 421-4600
--------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person Authorized to Receive Notices and
Communications)
MAY 22, 2003
--------------------------------------------------------------------------------
(Date of Event Which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G
to report the acquisition which is the subject of this Schedule 13D, and is
filing this schedule because of Rule 13d-1(e), (f) or (g), check the following
box [ ].
NOTE. Schedules filed in paper format shall include a signed original
and five copies of the schedule, including all exhibits. See Rule 13d-7(b) for
other parties to whom copies are to be sent.
* The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not
be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
--------------------------------------------------------------------------------
CUSIP No. 019222 10 8 13D Page 2 of 5 Pages
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
1 Names of Reporting Persons/I.R.S. Identification Nos. of Above
Persons (entities only)
WOODBOURNE PARTNERS, L.P.
--------------------------------------------------------------------------------
2 Check the Appropriate Box if a Member of a Group (See Instructions)
(a) [ ]
(b) [ ]
--------------------------------------------------------------------------------
3 SEC Use Only
--------------------------------------------------------------------------------
4 Source of Funds (See Instructions)
OO
--------------------------------------------------------------------------------
5 Check if Disclosure of Legal Proceedings is Required Pursuant to
Items 2(d) or 2(e) [ ]
--------------------------------------------------------------------------------
6 Citizenship or Place of Organization
MISSOURI
--------------------------------------------------------------------------------
Number of
7 Sole Voting Power
Shares
2,512,900.
Beneficially -------------------------------------------------
8 Shared Voting Power
Owned by
-0-
Each -------------------------------------------------
9 Sole Dispositive Power
Reporting
2,512,900.
Person With -------------------------------------------------
10 Shared Dispositive Power
-0-
--------------------------------------------------------------------------------
11 Aggregate Amount Beneficially Owned by Each Reporting Person
2,512,900.
--------------------------------------------------------------------------------
12 Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See
Instructions) [ ]
--------------------------------------------------------------------------------
13 Percent of Class Represented by Amount in Row (9)
32.2%
--------------------------------------------------------------------------------
14 Type of Reporting Person (See Instructions)
PN
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
CUSIP No. 019222 10 8 13D Page 3 of 5 Pages
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
1 Names of Reporting Persons/I.R.S. Identification Nos. of Above
Persons (entities only)
JOHN D. WEIL
--------------------------------------------------------------------------------
2 Check the Appropriate Box if a Member of a Group (See Instructions)
(a) [ ]
(b) [ ]
--------------------------------------------------------------------------------
3 SEC Use Only
--------------------------------------------------------------------------------
4 Source of Funds (See Instructions)
OO
--------------------------------------------------------------------------------
5 Check if Disclosure of Legal Proceedings is Required Pursuant to
Items 2(d) or 2(e) [ ]
--------------------------------------------------------------------------------
6 Citizenship or Place of Organization
UNITED STATES
--------------------------------------------------------------------------------
Number of
7 Sole Voting Power
Shares
2,537,100, SUBJECT TO THE DISCLAIMER IN ITEM 5.
Beneficially --------------------------------------------------------
8 Shared Voting Power
Owned by
26,300, SUBJECT TO THE DISCLAIMER IN ITEM 5.
Each --------------------------------------------------------
9 Sole Dispositive Power
Reporting
2,537,100, SUBJECT TO THE DISCLAIMER IN ITEM 5.
Person With --------------------------------------------------------
10 Shared Dispositive Power
26,300, SUBJECT TO THE DISCLAIMER IN ITEM 5.-
--------------------------------------------------------------------------------
11 Aggregate Amount Beneficially Owned by Each Reporting Person
2,563,400, SUBJECT TO THE DISCLAIMER IN ITEM 5.
--------------------------------------------------------------------------------
12 Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See
Instructions) [ ]
--------------------------------------------------------------------------------
13 Percent of Class Represented by Amount in Row (9)
32.7%
--------------------------------------------------------------------------------
14 Type of Reporting Person (See Instructions)
IN
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
CUSIP No. 019222 10 8 13D Page 4 of 5 Pages
--------------------------------------------------------------------------------
AMENDMENT NO. 7 TO SCHEDULE 13D
John D. Weil reported the acquisition of shares of Common Stock
("Stock") of Allied Healthcare Products, Inc., a Delaware corporation (the
"Issuer"), in an initial filing of this Schedule 13D on August 21, 1996, as
amended by Amendment No. 1 filed September 5 1996, Amendment No. 2 filed October
28, 1996, Amendment No. 3 filed May 28, 1997, Amendment 4 filed May 11, 1998,
Amendment No. 5 filed December 14, 1999, and Amendment No. 6 filed November 30,
2000. As reported in Amendment No. 3 filed May 28, 1997, all shares of Stock
previously reported as beneficially owned by Mr. Weil, members of his family
(other than Shares of Stock reported in Item 5 as held by Mr. Weil's son),
family trusts or the partnership controlled by Mr. Weil were transferred to
Woodbourne Partners, L.P. (the "Reporting Person").
The Cover Pages for Mr. Weil and for Woodbourne Partners, L.P. are
hereby amended as shown in this Amendment No. 7. Items 4, 5 and 6 are hereby
amended as follow. All other items are unchanged from the initial filing, as
previously amended.
ITEM 4. Purpose of the Transaction.
The owners listed in Item 5 purchased the Stock of the Issuer for
general investment purposes. The owners listed in Item 5 may acquire additional
shares of the Stock of the Issuer, based upon their respective investment
decisions.
In August of 1997, Mr. Weil was elected to the Board of Directors of
the Issuer and presently serves as the non-executive Chairman of the Board of
Directors of the Issuer.
ITEM 5. Interest in Securities of the Issuer.
(a) Subject to the disclaimer of beneficial ownership hereinafter
set forth, the Reporting Person hereby reports beneficial
ownership of 2,512,900 shares of Stock in the manner
hereinafter described:
Percentage of
Relationship to Number of Outstanding
Shares Held in Name of Reporting Person Shares Securities
---------------------- ---------------- ------------ -------------
Woodbourne Partners L.P. Reporting Person 2,512,900 32.2%
John D. Weil Sole Director and Shareholder of the
General Partner of the Reporting Person 50,500(1)(2) 0.6%
TOTAL 2,563,400 32.7%
============ ============
Notes:
(1) Includes 4,750 shares held directly, 4,000 shares held indirectly, 26,300
shares held by the spouse of John D. Weil, and 15,500 shares deemed beneficially
owned as the result of presently exercisable options held by John D. Weil.
(2) Does not include 10,000 shares held by an adult son of John D. Weil or 9,000
shares held by an Individual Retirement Account for the benefit of a person
holding a limited partnership interest in Woodbourne Partners L.P.
The foregoing percentages assume that the Issuer has 7,813,932 shares of
Stock outstanding as of May 15, 2003.
--------------------------------------------------------------------------------
CUSIP No. 019222 10 8 13D Page 5 of 5 Pages
--------------------------------------------------------------------------------
AS PROVIDED IN S.E.C. REGULATION Section 240.13d-4, JOHN D. WEIL HEREBY
DECLARES THAT THIS STATEMENT SHALL NOT BE CONSTRUED AS AN ADMISSION THAT HE IS,
FOR THE PURPOSES OF SECTION 13(d) OR 13(g) OF THE SECURITIES EXCHANGE ACT, THE
BENEFICIAL OWNER OF THE SECURITIES HELD BY HIS SPOUSE OR THE REPORTING PERSON
COVERED BY THIS STATEMENT.
(b) Subject to the above disclaimer of beneficial ownership, for each
person named in paragraph (a), the number of shares as to which
there is sole power to vote or direct the vote, shared power to vote
or direct the vote, sole power to dispose or direct the disposition,
or shared power to dispose or direct the disposition, is the same as
in paragraph (a).
(c)
Net
Number Price Transaction
Purchase/(Sale) in the Name of Date of Shares Per Share Made Through
------------------------------ ---- --------- --------- ------------
Woodbourne Partners, L.P. 5/21/03 5,200 3.06 Huntleigh Securities
Woodbourne Partners, L.P. 5/22/03 75,000 3.075 Huntleigh Securities
(d) Not applicable.
(e) Not applicable.
ITEM 6. Contracts, Arrangements, Understandings or Relationships With Respect to
Securities of the Issuer.
In August of 1997, Mr. Weil was elected to the Board of Directors of
the Issuer and presently serves as the non-executive Chairman of the Board of
Directors of the Issuer. As a director of the Issuer, Mr. Weil has received
options to acquire shares of the Issuer's Stock pursuant to the "Directors
Non-Qualified Option Plan" maintained by the Issuer (the "Plan"). As of May 22,
2003, such options covered an aggregate of 17,250 shares at exercise prices
ranging from $1.875 to $7.525 per share, of which options for 15,500 shares are
presently exercisable.
After reasonable inquiry, and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.
WOODBOURNE PARTNERS, L.P.,
by its General Partner, CLAYTON
MANAGEMENT COMPANY
/s/ John D. Weil
-----------------------------------
John D. Weil, President
JOHN D. WEIL
/s/ John D. Weil
-----------------------------------
May 27, 2003